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Abstract 
BACKGROUND: Although major reconstructive surgeries in the form of excision and reconstruction have been 
the mainstay treatment for Giant Cell Tumour (GCT) of the bone, its recurrence rate remains high and poses 
various morbidities such as implant failure or skin breakdown. Minimal invasive surgery (MIS) techniques, which 
has gained popularity mostly in other fields in orthopaedic surgery, are being introduced as an alternative to limit 
the surgical complications while achieving the best possible outcome. Until now, there has been no literature 
summarising the evidence of MIS outcome in treating GCT of the bone.  
AIM: The purpose of this systematic review was to investigate the efficacy of this relatively new treatment.  
METHODS: We comprehensively searched PubMed, EMBASE, and Cochrane Library to search for studies about 
MIS for GCT of the bone treatment up to March 1, 2019. The selection of appropriate studies was performed by 
two independent investigators based on PRISMA guideline. Given the limited number of studies, there was no 
restriction in terms of patient’s demographics, the specific minimally invasive surgical method, and publication 
status.  
RESULTS: We found 120 articles from the database. After evaluating full text, 5 articles (16 patients) were found 
to be eligible. The minimally invasive methods were curettage, cryosurgery, and argon beam coagulator. The 
visualisation methods include a computer-assisted navigation system, endoscope, otoscope, CT, and MRI. 
Location of tumours includes axial and long bones. The follow-up period ranges from 7 to 126 months. The 
functional and oncological outcome was found to be satisfying with no recurrence or complications.  
CONCLUSION: In conclusion, MIS is a familiar method in orthopaedic surgery with potential expansion in tumour 
field. The current evidence shows that this approach for GCT results in good functional outcome, with low risk of 
recurrence. 
 
 
 
 
Introduction 
 
Giant cell tumour (GCT) is a primary bone 
tumour with low metastatic potential, yet locally 
aggressive. Despite that surgery is the mainstay 
treatment for this entity; its recurrence rate remains 
high with < 20% for en block excision and 40%-50% 
for intralesional curettage [1]. Furthermore, radical 
resection of GCT has been known to result in poor 
functional outcome, especially in areas such as pelvis 
[2], [3]. Recently, minimally invasive techniques for 
treating GCT are being introduced to reduce the 
morbidity of GCT treatment while achieving treatment 
goals effectively. This study aims to review recent 
evidence concerning such treatment options 
systematically. 
The surgical approach towards localised GCT 
highly relates to significant damage to the surrounding 
tissue, hence the poor functional outcome. Adjunctive 
therapies were proposed as an alternative to manage 
GCT while minimising side effect. The therapies 
include pharmacologic therapies with RANKL 
inhibitors or bisphosphonates for patients with bad 
prognostic factors and radiotherapy (RT) for non-
resectable cases that are unresponsive to systemic 
drugs [4]. However, none of the adjunctive therapies 
was proven to be highly effective. 
Recently, minimally invasive techniques were 
offered as definitive therapy, which attempts to reduc 
morbidity to patients, resulting in faster recovery and 
less hospitalisation period. Minimally invasive surgery 
is defined as a surgical procedure that is done using 
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state-of-the-art technology to reduce the damage to 
human tissue when performing surgery. Minimally 
invasive surgery uses a small incision to create small 
"ports" from which the surgeon inserts small 
instruments. A miniature camera can be placed inside 
to view the procedure as a magnified image on video 
monitors in the operating room. Other specialised 
small surgical instruments can then insert through the 
trocars based on the type of surgery. Cryoablation 
method, for example, utilised 4 probes and the patient 
underwent minimum pain relieved by basic analgesic 
[5]. It is usually combined with the computer 
navigation system to navigate the limited visual field 
[6]. These methods have gained popularity mostly in 
other fields in orthopaedic surgery, with the possibility 
of expanding its use in the orthopaedic oncology field. 
Despite the potential of MIS, there has never 
been any literature summarising this latest trend of 
minimally invasive techniques for treating GCT. To 
advance it even further, a thorough analysis of 
previously treated cases, the specific indication, the 
methods used along with its advantages and 
disadvantages, and other lessons learned should be 
performed. This systematic review aims at presenting 
current evidence about the efficacy of this relatively 
new treatment for GCT. 
 
 
Materials and Methods 
 
Search strategy 
This systematic review was conducted based 
on PRISMA guideline. Literature research was 
primarily performed using the Pubmed, EMBASE, and 
Cochrane Library to search for studies about MIS for 
GCT of the bone treatment up to March 1, 2019, with 
the keywords: 1. “giant cell tumour” AND “minimally 
invasive”; and 2. “giant cell tumour” AND 
“endoscopic”. 
We filtered the search to include only studies 
in human, published in the last 10 years, and ones 
written in English. After that, we combed through all 
articles cited and citing the articles so as not to miss 
any relevant articles. 
 
Inclusion criteria 
Inclusion and exclusion criteria of this study 
were described using the method of PICO 
(Population, Intervention, Comparison, and Outcome) 
(Table 1). The inclusion criteria were GCT of bone in 
any location, with the intervention of minimally 
invasive surgery as compared to conventional open 
surgery, and recurrence rate and hospitalisation 
period as an outcome. Case reports and case series 
were also included. Given the limited number of 
studies, there was no restriction in terms of patient’s 
demographics, the specific minimally invasive surgical 
method, and publication status. We excluded all cases 
of GCT of soft tissue and ones located in the cranium. 
 
Quality evaluation 
First, all authors screened eligible studies 
through the titles and abstracts based on inclusion 
criteria. Then, all authors screened the full articles of 
all the collected studies. The authors had a meeting 
and agreed on highly relevant publications to be 
included in this study. All authors performed an 
appraisal of study quality independently and any 
disagreement was resolved through discussion. 
All inherent aspects of the studies, including 
study quality, variables for which data were sought, 
and assessment of the risk of bias, were appraised by 
all authors independently by filling up forms. The 
forms were collected by the first author and the 
contents were scanned for any disagreement. The 
authors then gathered again for discussing any 
contradicting points. 
 
 
Results 
 
The electronic search resulted in 120 records, 
after the elimination of duplicate results. Based on 
titles and abstracts screening, a total of 99 records 
were excluded. The remaining articles were 
subsequently studied by two independent 
investigators based on the full text extracted. A list of 
inclusion and exclusion criteria (Table 1) previously 
agreed by the three authors were utilised for 
screening the full text. This selection process yielded 
5 final articles to be included in the systematic review 
and was depicted in Figure 1. 
 
Figure 1: Article selection based on PRISMA Guidelines 
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 In total, 16 patients were eventually included 
in the analysis. Among these patients, 3 patients had 
surgeries in the axial bones (vertebral body, sacrum, 
and pelvis) while the remaining 13 patients were of 
long bones (femur, tibia, and fibula). The axial bone 
group had a CT guided procedure to treat the GCT. In 
the long bones group, image intensifier was utilised 
for all 13 patients [5], [7]. 
Table 1: PICO Table Describing Inclusion and Exclusion 
Criteria 
Study Component Inclusion Exclusion 
Population Any age 
Patients with Giant Cell 
Tumour of the bone in any 
location 
Animal studies 
Patients with benign neoplasms other 
than GCT of the bone 
Infection or deformity 
Intervention Minimally invasive surgery 
as primary treatment for 
GCT 
Adjunctive therapies for GCT 
Minimally invasive surgery as a 
treatment for GCT complication 
Outcome Functional outcome 
Oncological outcome 
Radiological outcome 
Publication Studies published in 
English in peer-reviewed 
journals 
Any publication year 
Abstracts, editorials, letters 
Duplicate publications of the same study 
that do not report on different outcomes 
Meeting presentations or proceedings 
Study Design All study design - 
 
Among them, 8 patients underwent the 
procedure with endoscope or osteoscope through a 
small incision, and the other 5 patients did not have 
additional visualisation inside the lesion [6], [8], [9]. 
The indication for studies of MIS of GCT in axial 
bones was tumours with high morbidity and failed 
conventional treatment [5], [7]. As for studies of long 
bones GCT, special attention was given to lesions 
around joint and one that still has cortical wall even 
though thin [6], [8], [9]. The summary of used methods 
and their indications were described in Table 2. 
Table 2: Summary of minimally invasive methods recorded in 
the literature 
No Author Method Navigation Indication 
Axial bones 
1 Takeda, 2009 [7]
 
Curettage and 
argon beam 
coagulator 
CT and MRI Sacral and spinal GCT of 
bone 
2 Panizza, 2015 [5]
 
Cryoablation CT-guided Extensive pelvic bone 
tumour. Failure of clinical 
treatment with denosumab 
and refusal of 
hemipelvectomy. 
Long bones 
3 Robinson, 2004 
[8]
 
Argon-based 
cryosurgery 
Image 
intensifier 
Lesions close to joint 
4 Wong, 2010 [6]
 
Intralesional 
curettage and bone 
cement 
Computer-
assisted 
navigation and 
endoscope 
Benign bone tumours 
without extraosseous 
extension. 
5 Futani, 2018 [9]
 
Curettage and 
adjuvants of argon 
plasma coagulation 
(APC). 
Osteoscopy 
with 30
o
 
endoscope. 
GCT was developing in the 
proximal fibula. Tumour 
located inside the bone 
cavity surrounded by a 
cortical wall, even if this is 
thin. 
 
The baseline characteristic of the study of 
Robinson (2004) was not described in details. As for 
the other studies, the patients were aged between 17 
until 59 years old, and most were male (Table 3). The 
characteristic of the tumour was similar for the axial 
bones, a large lytic lesion in the sacrum, vertebral 
body, and pelvis. In the study by Panizza (2015), the 
pelvic tumour was described to have well-defined and 
sclerotic borders. While for the long bones, the 
tumours were of Campanacci grade 2-3 and located in 
femur, tibia, and fibula. 
Table 3: Baseline Characteristics of Patients 
No Author Number of 
patients 
Age Gender Tumour 
characteristics 
Location 
Axial bones 
1 Takeda, 
2009 [7] 
2 46 F Large purely lytic 
process. 
Right hemisacrum 
25 M Large osteolytic 
lesion 
L5 vertebral body, 
expanding to the 
spinal canal 
2 Panizza, 
2015 [5] 
1 45 M Large lytic, 
expansible, a 
locally aggressive 
lesion with well-
defined and 
sclerotic borders. 
Pelvis 
Long bones 
3 Robinson, 
2004 [8] 
5 NA NA NA Proximal fibula [1], NA 
[4] 
4 Wong, 2010 
[6] 
3 47 M NA Right medial distal 
femur 
34 F NA Left proximal lateral 
tibia 
26 F NA Right lateral distal 
femur 
5 Futani, 
2018 [9] 
5 17-59 All male Campanacci grade 
2-3 
Proximal fibula 
Abbreviations: NA, not available. 
 
Patients of GCT in axial bones had follow-up 
between 60-74 months, and long bones GCT between 
7-126 months. The outcome for axial bones GCT was 
overall satisfying, with the preserved function of lower 
limbs, bladder and bowel, and no recurrence or 
metastasis. There was however a movement 
impairment of hallux for pelvic tumour reconstruction 
case. MIS for long bones yielded an acceptable result 
with mean early postoperative VAS of 2.2 (range, 1-
3), full ROM and unaided walking, no knee instability 
or decreased Tegner scores, and MSTS of 100%. The 
oncological outcome was good without any metastasis 
or recurrence except on one patient with tumour 
recurrence at proximal fibula (Table 4). 
Table 4: Functional outcome of each study 
No Author Follow up 
(months) 
Functional Outcome Oncological Outcome 
Axial bones 
1 Takeda, 2009 
[7] 
60-74 The function of lower limbs, 
bladder, and bowel preserved. 
No recurrence. 
2 Panizza, 2015 
[5] 
NA Able to walk a 10 km distance. 
Movement impairment of hallux. 
No local or metastatic 
progression of tumor. 
Long bones 
3 Robinson, 
2004 [8] 
24 NA Tumour recurrence at the 
proximal fibula. 
4 Wong, 2010 
[6] 
7-9 Mean early postoperative VAS 
2.2 (range, 1-3). 
All patients had full ROM and 
walked unaided at 4 weeks post-
surgery. 
No local recurrence. 
Good cementation of the 
skeletal defect. 
5 Futani, 2018 
[9] 
24-126 Knee instability negative in all 
cases. 
Mean MSTS rating was 100%. 
Tegner scores the same as 
before surgery. 
No local recurrence. 
No pulmonary 
metastasis. 
Abbreviations: NA, not available; VAS, Visual Analog Scale. 
 
Quality of evidence was assessed with all 
studies categorised as level IV.  
Table 5: Characteristics of journals used in the study 
No Reference Journal Study Design 
Level of 
Evidence 
1 Takeda, 2009 [7] Journal of Orthopaedic Science Case Series Level IV 
2 Panizza, 2015 [5]
 Cardiovascular and Interventional 
Radiological Society of Europe 
Case Report Level IV 
3 Robinson, 2004 [8]
 Technology in Cancer Research & 
Treatment 
Case Series Level IV 
4 Wong, 2010 [6] Computer-Aided Surgery Case Series Level IV 
5 Futani, 2018 [9] Anticancer Research Case Series Level IV 
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Each one had the different instrument to 
assess the functional outcome, while the oncological 
outcome was assessed almost similarly according to 
recurrence and metastasis rate (Table 5). 
 
 
Discussion 
 
The traditional method of managing locally 
aggressive bone tumour such as GCT includes intra-
lesional curettage followed by local adjuvants. The 
bone is decorticated to access the tumour, which is 
then curetted. The osseous surface of the tumour 
cavity is then cleared using high-speed burr. This 
conventional invasive method inflicts a lot of damage 
to the living tissue, something that could be improved 
by introducing a less invasive approach. The 
advantage of the minimally invasive approach is 
particularly the decrease of morbidity in GCT of axial 
bones and the function preservation of periarticular 
lesions of long bones. 
One of the problems commonly found 
regarding GCT treatment is a local recurrence and 
increased risk of pulmonary metastases. In surgically 
inaccessible lesions such as spine and pelvis, 
sometimes the lesion cannot be completely resected, 
further contributing to this problem. Conventional 
treatment using curettage with or without adjunct, 
burring, bone cement, H2O2, and/or sponge-bone 
have not proven to be satisfactory in terms of 
outcome, as well as wide resection procedure. 
Furthermore, the recurrence rate was still high (± 
30.8%), and even more in long bones (45.5-88.9%). 
Pulmonary metastases rate was ± 3.3%, not to 
mention the possible metastases in other organs, 
such as soft tissue, brain, and small intestine, 
resulting in increased mortality and hospitalisation 
cost [10]. 
In a study by van der Heiden et al., (2014), en 
bloc resection was known to result in the lowest 
recurrence rate (0-16%). However, this procedure has 
higher complication risk, increased possibility of the 
subsequent need for revision surgery, and worse 
functional outcome compared to MIS. For GCT of 
axial bones, invasive surgery may result in higher 
morbidity, as it may increase the possibility of 
bleeding, infection, neurological deficits, bladder, 
rectal, and sexual dysfunction [2]. 
 
MIS for GCT of axial bones 
Sacral GCT is a rare difficult case, and there 
are still controversies on the optimal treatments for the 
lesion. Conventional methods still result in a low rate 
of tumour control, high rate of complications and 
functional outcome. It is even more challenging when 
the defect is significantly large that excessive bleeding 
and pelvic instability might ensue after resection [11], 
[12], [13]. Extensive surgery might also damage 
neighbouring nerves and may result in cauda equina 
syndrome. Bladder and rectal dysfunction also lead to 
increased morbidity [14], [15]. The restricted use of 
radiotherapy for sacral GCT (as it may result in 
radiation-induced sarcoma) makes the conventional 
treatment more difficult [16]. 
In this study, we interpret “less invasive” as an 
approach which introduces less damage to tissue than 
mainstay treatment. This is especially true for GCT of 
axial bones whose conventional treatment is complete 
excision, including complete removal of sacral nerve 
roots [5], [7]. Aiming at minimal damage to 
surrounding tissues, the surgeons devised minimal 
invasive procedures using curettage and argon beam 
coagulator [7] or cryoablation [5] while protecting 
relevant nerve roots throughout procedure under 
direct visualisation. In one case where nerve injury still 
occurred despite the precautions, Panizza et al., 
(2015) recommended the electrophysiological 
monitoring in addition to displacement techniques 
using gas or fluid to protect the nerve roots. 
 
MIS for GCT near joint of long bones 
Some serious postoperative complications 
associated with resection of GCT of the proximal 
fibula are peroneal nerve palsy and local recurrence. 
Local recurrence rate differs depending on tumour 
histology and resection type, while the incidence of 
postoperative peroneal nerve palsy ranges from 3% to 
57% [17] and closely relates to the patient’s functional 
outcome. The fate of the peroneal nerve here also 
depends on preoperative chemotherapy response, 
which if the tumour responds well, then the amount of 
tissue resected can be minimalised and the peroneal 
nerve can be more well preserved. In patients with 
peroneal nerve palsy, the functional outcome is lower 
and peroneal braces might be needed [18]. For 
selected patients, MIS techniques in treating GCT of 
the bone in certain locations of the body have 
advantages such as preservation of anatomically 
important tissue and also the possibility of intra-
lesional resection. Futani et al. (2018) used MIS to 
treat GCT at the proximal fibula since the area is 
highly important for knee stability. MIS allowed 
thorough tumour removal without compromising 
ligaments attached around that area. 
The other highlight of this technique is the use 
of magnification with equipment which provides 
excellent visualisation of the bone cavity. Direct 
visualisation can be provided by osteoscopy or 
endoscopy which magnifies the inside of lesion onto 
large monitors, enabling surgeons to identify small 
residual tumours [6], [9]. Additionally, the computer 
navigation system can also be used to confirm 
whether the curettage is already as thorough as a 
preoperative plan [6]. A combination of these 
visualisation methods permits assurance of complete 
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curettage without compromising the tissue too much. 
Limitation of MIS: Despite the success of the 
studies presented, there are still limitations. 
Cryoablation in the study of Panizza, 2016, was 
performed in 2 stages after ensuring that the first 
stage did not yield unwanted necrosis of adjuvant 
tissues, a reported complication of the surgery [19]. 
Cryoablation technique might also be challenging 
when it comes to treating a large complex bone 
lesion, where multiple probes and imaging might be 
needed to plan serial repositioning sessions [5]. 
Whereas in argon beam coagulator technique for 
treating GCT of axial bones, there is a risk of 
damaging neural tissue, when the tip of the nozzle is 
initiated before reaching at least 1 cm of the tissue 
surface [7]. For extraskeletal lesions, osteoscopic 
surgery method should also be used cautiously, 
where if the lesion fails to create a sclerotic wall using 
denosumab, then this method is no longer suitable to 
apply [9]. In general, MIS requires surgeons who are 
well-adapted to endoscopic and navigation surgeries. 
Furthermore, the novelty of the system results 
in higher cost and the need for sophisticated 
supporting facilities. Wong et al., (2010) also hoped 
that in the future, there would be an established 
navigation software system along with more 
developed special tools for endoscopic tumour 
surgery, to facilitate this advanced method of 
treatment [6]. There is a need for future studies with 
better study design to assess the added value of 
developing and utilising sophisticated equipment for 
treating GCT of the bone. 
In conclusion, despite the limited number of 
studies, MIS yields satisfying functional and 
oncological outcome for GCT around axial bones and 
long bones. In axial bones, MIS has a particular role in 
treating GCT of spine and pelvis with high morbidity 
by negating the need of en bloc resection. There are 
also certain benefits of treating GCT of long bones 
with periarticular lesions. The most prominent 
advantage of MIS is its excellent intralesional 
visualisation with equipment which has been widely 
utilised in orthopaedics fields, thus reducing the cost 
of developing sophisticated new equipment. However, 
further cost-benefit analysis is needed to justify the 
addition of these sophisticated equipment. 
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